Estimating the costs of opioid abuse and dependence from an employer perspective: A retrospective analysis using administrative claims data

Applied Health Economics and Health Policy

Volumn 12, Issue 4, 2014, Pages 435-446

  Rice, J Bradford ^a   Kirson, Noam Y ^a   Shei, Amie ^a   Cummings, Alice Kate G ^a   Bodnar, Katharine ^a   Birnbaum, Howard G ^a   Ben Joseph, Rami ^b  

^a ANALYSIS GROUP   (United States)

^b PURDUE PHARMA L P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ADOLESCENT; ADULT; ARTICLE; DRUG ABUSE; EMPLOYEE; EMPLOYER; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MALE; OPIATE ADDICTION; PRESCRIPTION; PROPENSITY SCORE; RETROSPECTIVE STUDY; SCORING SYSTEM; UNITED STATES; WORK; COST; DRUG USE; ECONOMICS; EMPLOYMENT; INSURANCE; MEDICAL LEAVE; MIDDLE AGED; OCCUPATIONAL HEALTH; OPIOID-RELATED DISORDERS; PREVALENCE; YOUNG ADULT;

ADULT; COSTS AND COST ANALYSIS; DRUG USERS; EMPLOYMENT; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MIDDLE AGED; OCCUPATIONAL HEALTH; OPIOID-RELATED DISORDERS; PREVALENCE; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SICK LEAVE; UNITED STATES; YOUNG ADULT;

EID: 84905087206     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-014-0102-0     Document Type: Article

References (25)

1. Institute of Medicine. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: National Academies Press, 2011.
2. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443-54. (Pubitemid 37430544)
3. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305:1346-7.
4. IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2011. April 2012. http://www.imshealth.com/ims/Global/ Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/ IHII-Medicines-in-U.S-Report-2011.pdf. Accessed 1 Sept 2013.
5. Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: national findings. Rockville: Substance Abuse and Mental Health Services Administration, 2007. http://www.samhsa.gov/data/nsduh/2k6nsduh/2k6results.pdf. Accessed 1 Aug 2013.
6. Substance Abuse and Mental Health Services Administration. Results from the 2011 National Survey on Drug Use and Health: summary of national findings. Rockville: Substance Abuse and Mental Health Services Administration, 2012. http://www.samhsa.gov/data/NSDUH/2k11Results/NSDUHresults2011.htm. Accessed 1 Aug 2013.
7. Rice JB, White AG, Birnbaum HG, Schiller M, Brown DA, Roland CL. A model to identify patients at risk for prescription opioid abuse, dependence, and misuse. Pain Med. 2012;13:1162-73.
8. Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12:657-67.
9. White AG, Birnbaum HG, Schiller M, Waldman T, Cleveland JM, Roland CL. Economic impact of opioid abuse, dependence, and misuse. Am J Pharm Benefits. 2011;3:e59-70.
10. Strassels SA. Economic burden of prescription opioid misuse and abuse. J Manag Care Pharm. 2009;15(7):556-62.
11. McAdam-Marx C, Roland CL, Cleveland J, Oderda GM. Costs of opioid abuse and misuse determined from a Medicaid database. J Pain Palliat Care Pharmacother. 2010;24(1):5-18.
12. Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among US adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94:38-47.
13. Substance-Related and Addictive Disorders. American Psychiatric Association. http://www.dsm5.org/Documents/ Substance%20Use%20Disorder%20Fact%20Sheet.pdf. Accessed 21 Mar 2014.
14. White AG, Birnbaum HG, Mareva MN, et al. Direct costs of opioid abuse in an insured population in the United States. J Manag Care Pharm. 2005;11:469-79.
15. White AG, Birnbaum HG, Rothman DB, Katz N. Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction. Appl Health Econ Policy. 2009;7:61-70.
16. Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46:399-424.
17. Rice JB, Desai U, Cummings AKG, Birnbaum HB, Skornicki M, Parsons N. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2014;37:651-8.
18. Johnson SJ, Kaltenboek A, Diener M, Birnbaum HG, Grubb E, Castelli-Haley J, Siderowf AD. Costs of Parkinson's disease in a privately insured population. Pharmacoeconomics. 2013;31:799-806.
19. US Bureau of Labor Statistics. Consumer Price Index. Washington DC, 2013. http://www.bls.gov/cpi/home.htm. Accessed 8 May 2014.
20. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075-9.
21. Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999. J Occup Environ Med. 2003;45(1):5-14. (Pubitemid 36091516)
22. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. Rockville: Substance Abuse and Mental Health Services Administration, 2011. http://www.samhsa.gov/data/NSDUH/2k10ResultsRev/NSDUHresultsRev2010.htm. Accessed 16 Jan 2014.
23. Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: summary of national findings. Rockville: Substance Abuse and Mental Health Services Administration, 2013. http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/ NSDUHresults2012.htm. Accessed 16 Jan 2014.
24. Long DA, Reed R, Lehman G. The cost of lifestyle health risks: obesity. J Occup Environ Med. 2006;48:244-51.
25. Katz NP, Birnbaum H, Brennan MJ, Freedman JD, Gilmore GP, Jay D, Kenna GA, Madras BK, McElhaney L, Weiss RD, White AG. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013;19(4):295-302.